# Christopher J Edwards

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/christopher-j-edwards/

## Facts

| Field | Value |
| --- | --- |
| Citations | 12,942 |
| Field | Rheumatoid Arthritis Research and Therapies |
| h-index | 48 |
| i10-index | 127 |
| Last Known Institution | University Hospital Southampton NHS Foundation Trust |
| OpenAlex ID | https://openalex.org/A5080267247 |
| ORCID iD | 0000-0002-8233-6602 |
| Works | 298 |

## Researcher papers

- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-2/)
- [EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update](https://scholariq.org/papers/eular-recommendations-for-the-management-of-rheumatoid-arthritis-with-synthetic-3/)
- [EULAR recommendations for the use of imaging of the joints in the clinical management of rheumatoid arthritis](https://scholariq.org/papers/eular-recommendations-for-the-use-of-imaging-of-the-joints-in-the-clinical/)
- [Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial](https://scholariq.org/papers/rituximab-versus-tocilizumab-in-anti-tnf-inadequate-responder-patients-with/)
- [2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations](https://scholariq.org/papers/2014-update-of-the-eular-standardised-operating-procedures-for-eular-endorsed/)
- [Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)](https://scholariq.org/papers/apremilast-an-oral-phosphodiesterase-4-inhibitor-in-patients-with-psoriatic/)
- [Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome](https://scholariq.org/papers/randomized-controlled-trial-of-rituximab-and-cost-effectiveness-analysis-in/)
- [Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative](https://scholariq.org/papers/multinational-evidence-based-recommendations-for-the-diagnosis-and-management-of/)
- [Knee pain, knee osteoarthritis, and the risk of fracture](https://scholariq.org/papers/knee-pain-knee-osteoarthritis-and-the-risk-of-fracture/)
- [Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review](https://scholariq.org/papers/rheumatoid-arthritis-the-impact-of-mental-health-on-disease-a-narrative-review/)
- [Differences in management approaches for lupus nephritis within the UK](https://scholariq.org/papers/differences-in-management-approaches-for-lupus-nephritis-within-the-uk/)

## Researcher topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Autoimmune and Inflammatory Disorders Research](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders-research/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

## Researcher university

- [University Hospital Southampton NHS Foundation Trust](https://scholariq.org/institutions/university-hospital-southampton-nhs-foundation-trust/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.